David Miles
Cardiovascular Disease · Baker, FLNPI 1477542223
Payments from drug & device makers
Across 237 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$737
- Novartis$647
- Amgen$429
- Johnson & Johnson$354
- E.r. Squibb & Sons, L.L.C.$322
- Astellas Pharma US Inc$188
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $737 |
| Novartis | 57 | $647 |
| Amgen | 31 | $429 |
| Johnson & Johnson | 30 | $354 |
| E.r. Squibb & Sons, L.L.C. | 17 | $322 |
| Astellas Pharma US Inc | 12 | $188 |
| Regeneron Healthcare Solutions, Inc. | 5 | $185 |
| Pfizer | 20 | $173 |
| Boston Scientific | 6 | $112 |
| Merck | 6 | $111 |
| Sanofi-aventis U.S. LLC | 5 | $105 |
| Actelion Pharmaceuticals US, Inc. | 6 | $90 |
| Boehringer Ingelheim | 5 | $89 |
| AstraZeneca | 6 | $77 |
| Amarin Pharma, Inc. | 3 | $59 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Akcea Therapeutics, Inc. | 2 | $36 |
| Gilead | 3 | $36 |
| Portola Pharmaceuticals, LLC | 2 | $31 |
| Bayer | 2 | $29 |
| Lundbeck LLC | 1 | $23 |
| GE HealthCare | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,897 in reported general payments places this provider in the 50th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Baker
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.